Mitsubishi Tanabe Pharma News and Activities

Mitsubishi Tanabe Pharma is a company listed under the stock ticker 4508 (JP).

Mitsubishi Tanabe Pharma has a direct presence in 6 countries.

Mitsubishi Tanabe Pharma has 5 subsidiaries including Mitsubishi Tanabe Pharma America, Mitsubishi Tanabe Pharma Canada and Mitsubishi Tanabe Pharma Europe.

Acquisition, funding and merger involving Mitsubishi Tanabe Pharma.

• Tanabe Pharma Corporation will change its company name to Tanabe Pharma Corporation on Dec 1, 2025. (posted on November 12 2025).
• Bain Capital has acquired Mitsubishi Tanabe Pharma (posted on February 12 2025).

View the org chart displaying its 70 main executives

Most searched biographies at Mitsubishi Tanabe Pharma

• Akihisa Harada, Chief Executive Officer
• Costa Saroukos, Chairman of the Board
• Ryousuke Tanabe, Director

Popular executive movements at Mitsubishi Tanabe Pharma

• Masahiko Ohtsuki has joined the company as Chief Research and Development Officer  (posted on May 12 2026).
• Hajime Minami has joined the company as Executive Officer, Head of Sales  (posted on May 12 2026).
• Shintaro Kohmoto who was Director, becomes Chief Transformation Officer and General Counsel  (posted on May 12 2026).

Click here to view some more movements at Mitsubishi Tanabe Pharma

Create your alert
to follow the executive moves at Mitsubishi Tanabe Pharma.

Mitsubishi Tanabe Pharma has 1,912 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Mitsubishi Tanabe Pharma

• Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Chemical Group | Mitsubishi Tanabe Pharma Corporation
• Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Chemical Group | Mitsubishi Tanabe Pharma Corporation
• Support for the Earthquake Victims in Turkey and Syria | Mitsubishi Tanabe Pharma Corporation
• Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Chemical Group | Mitsubishi Tanabe Pharma Corporation
• Mitsubishi Chemical Group ― Notice on Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023 | Mitsubishi Tanabe Pharma Corporation
• Notice of Award for the Arbitration Filed against Mitsubishi Tanabe Pharma Corporation, a Consolidated Subsidiary of Mitsubishi Chemical Group Corporation | Mitsubishi Tanabe Pharma Corporation
• Overseas Consolidated Subsidiary, Medicago to Cease Operations | Mitsubishi Tanabe Pharma Corporation
• Mitsubishi Chemical Group Announces New Group Concept (Purpose, Slogan, Our Way) | Mitsubishi Tanabe Pharma Corporation
• Personnel Changes of the Mitsubishi Chemical Group | Mitsubishi Tanabe Pharma Corporation
• Please beware of “spoofing e-mails, messages, etc.” that impersonate executives of Mitsubishi Tanabe Pharma Corporation (MTPC). | Mitsubishi Tanabe Pharma Corporation
• View more press releases Close

Social media about Mitsubishi Tanabe Pharma

• Mitsubishi Tanabe Pharma on Wikipedia, Google News & Yahoo Finance
• Mitsubishi Tanabe Pharma on LinkedIn, X (Twitter) & YouTube